Detailed explanation of Rubicatin drug prices and purchasing information
Lurbinectedin (Lurbinectedin), as an injectable drug specifically targeting spread of small cell lung cancer (SCLC), is attracting the attention of more and more patients. This type of drug belongs to the alkylating agent class, and its main mechanism of action is to inhibit or slow down the spread of cancer cells by interfering with their normal growth cycle.
In terms of use, rubicatin is usually provided in powder form and mixed with a suitable liquid for intravenous injection by a professional medical practitioner. The entire injection process needs to be strictly controlled to be completed within 60 minutes. To ensure treatment effectiveness and patient safety, it is recommended to perform injection treatment every 21 days. However, the actual treatment cycle may be adjusted based on individual patient differences, drug response, and possible side effects.

There are certain risks when using Rubicatin. Especially at the injection site, the drug may leak into surrounding tissues, causing pain, redness, swelling, itching and other uncomfortable reactions, and may even cause more serious tissue damage. Therefore, patients need to pay close attention to changes at the injection site during treatment and notify their doctor immediately if any abnormal reactions occur.
Regarding the purchase of Rubicatin, the original version of the drug has not yet been launched in China, so patients cannot purchase it directly through domestic channels. It is understood that there are currently two original Rubicatin drugs available in the overseas market: the US version and the Singapore version. Among them, the price of the American version is roughly more than 90,000 yuan, while the Singapore version is relatively cheap, priced at about more than 30,000 yuan. However, please note that these prices are for reference only and may change at the time of actual purchase due to exchange rate fluctuations and other factors. There is currently no generic version of Rubicatin on the overseas market.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)